{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T03:04:45Z","timestamp":1785207885332,"version":"3.55.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL138728"],"award-info":[{"award-number":["R01HL138728"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL153611"],"award-info":[{"award-number":["R01HL153611"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL138728"],"award-info":[{"award-number":["R01HL138728"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL153611"],"award-info":[{"award-number":["R01HL153611"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>C-reactive protein (CRP) has demonstrated utility as a point-of-care triage test for tuberculosis (TB) in clinical settings, particularly among people with human immunodeficiency virus (HIV), but its performance for general-population TB screening is not well characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the accuracy of CRP for detecting pulmonary TB disease among individuals undergoing community-based screening or presenting for evaluation of TB symptoms in Kampala, Uganda.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We pooled data from two case\u2013control studies conducted between May 2018 and December 2022 among adolescents and adults (\u2a7e15\u2009yr) in Kampala, Uganda. We conducted community-based screening for TB, regardless of symptoms. We enrolled people with Xpert MTB\/RIF Ultra\u2013positive (including trace) sputum results and a sample of people with Ultra-negative results. We also enrolled symptomatic patients diagnosed with TB and controls with negative TB evaluations from ambulatory care settings. Participants underwent further evaluation, including sputum culture, CRP, and HIV testing. We assessed the accuracy of CRP alone or with symptom screening against a bacteriologic reference standard. Our primary analysis evaluated the sensitivity and specificity of CRP at a cutoff of 5\u2009mg\/L. Diagnostic performance was summarized by calculating the area under the receiver operating curve (AUC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the community setting (n\u2009=\u2009544), CRP\u2009\u2a7e\u20095\u2009mg\/L had a sensitivity of 55.3% (95% confidence interval, 47.0\u201363.4%) and specificity of 84.7% (79.7\u201388.8%) for confirmed TB; AUC was 0.75 (0.70\u20130.79). Screening for CRP\u2009\u2a7e\u20095\u2009mg\/L or positive symptoms increased sensitivity to 92.0% (86.4\u201395.8%) at the expense of specificity (57.1% [50.8\u201363.2%]). In the ambulatory care setting (n\u2009=\u2009944), sensitivity of CRP\u2009\u2a7e\u20095\u2009mg\/L was 86.7% (81.8\u201390.7%), specificity was 68.6% (64.8\u201372.2%), and AUC (0.84 [0.81\u20130.87]) did not differ significantly by HIV status. CRP\u2009\u2a7e\u20095\u2009mg\/L was &amp;gt;90% sensitive among individuals with a medium or high semiquantitative Xpert result in both settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although CRP did not meet World Health Organization (WHO) TB screening benchmarks in the community, it demonstrated high specificity, and sensitivity was high among individuals with high sputum bacillary burden who are likely to be most infectious. In ambulatory care, estimated sensitivity and specificity were each within 4 percentage points of WHO benchmarks, with no meaningful difference in performance by HIV status.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202308-752oc","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T09:00:13Z","timestamp":1706000413000},"page":"875-883","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":14,"title":["Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda"],"prefix":"10.1093","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9953-1693","authenticated-orcid":false,"given":"Samyra R.","family":"Cox","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamoga Caleb","family":"Erisa","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-216X","authenticated-orcid":false,"given":"Peter James","family":"Kitonsa","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"},{"name":"College of Health Sciences, Makerere University, Mulago Hill, Kampala, Uganda; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3903-303X","authenticated-orcid":false,"given":"Annet","family":"Nalutaaya","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5696-0703","authenticated-orcid":false,"given":"Mariam","family":"Nantale","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Kayondo","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Mukiibi","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0607-2913","authenticated-orcid":false,"given":"Michael","family":"Mukiibi","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Nakasolya","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0481-7475","authenticated-orcid":false,"given":"David W.","family":"Dowdy","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland"},{"name":"College of Health Sciences, Makerere University, Mulago Hill, Kampala, Uganda; and"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2347-4183","authenticated-orcid":false,"given":"Achilles","family":"Katamba","sequence":"additional","affiliation":[{"name":"Uganda Tuberculosis Implementation Research Consortium, World Alliance for Lung and Intensive Care Medicine in Uganda (WALIMU), Kampala, Uganda"},{"name":"College of Health Sciences, Makerere University, Mulago Hill, Kampala, Uganda; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0083-422X","authenticated-orcid":false,"given":"Emily A.","family":"Kendall","sequence":"additional","affiliation":[{"name":"College of Health Sciences, Makerere University, Mulago Hill, Kampala, Uganda; and"},{"name":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,6,1]]},"reference":[{"key":"2026012203154661400_bib1","volume-title":"Global tuberculosis report 2022","author":"World Health Organization","year":"2022"},{"key":"2026012203154661400_bib2","doi-asserted-by":"crossref","first-page":"eabj4124","DOI":"10.1126\/scitranslmed.abj4124","article-title":"Point-of-care diagnostic tests for tuberculosis disease","volume":"14","author":"Hong","year":"2022","journal-title":"Sci Transl Med"},{"key":"2026012203154661400_bib3","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiu821","article-title":"Defining the needs for next generation assays for tuberculosis","volume":"211","author":"Denkinger","year":"2015","journal-title":"J Infect Dis"},{"key":"2026012203154661400_bib4","first-page":"CD010890","article-title":"Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status","volume":"3","author":"Van\u2019t Hoog","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012203154661400_bib5","volume-title":"WHO consolidated guidelines on tuberculosis. Module 2: screening\u2014systematic screening for tuberculosis disease","author":"World Health Organization","year":"2021"},{"key":"2026012203154661400_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.5588\/ijtld.17.0078","article-title":"Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis","volume":"21","author":"Yoon","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203154661400_bib7","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1473-3099(17)30488-7","article-title":"Point-of-care C-reactive protein-based tuberculosis screening for people living with HIV: a diagnostic accuracy study","volume":"17","author":"Yoon","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026012203154661400_bib8","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1093\/cid\/ciaa1824","article-title":"The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities","volume":"72","author":"Kendall","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026012203154661400_bib9","article-title":"Evidence for tuberculosis in individuals with Xpert Ultra \u201ctrace\u201d sputum during screening of high-burden communities","author":"Sung","journal-title":"Clin Infect Dis"},{"key":"2026012203154661400_bib10","volume-title":"2011 Uganda HIV indicators survey","author":"Republic of Uganda, Ministry of Health","year":"2012"},{"key":"2026012203154661400_bib11","volume-title":"Uganda National TB Prevalence Survey 2014\u20132015","author":"Republic of Uganda, Ministry of Health","year":"2017"},{"key":"2026012203154661400_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.5588\/ijtld.22.0607","article-title":"Higher yield using an event-based vs. door-to-door approach for active case-finding for TB","volume":"27","author":"Malhotra","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026012203154661400_bib13","volume-title":"Ugandan National Tuberculosis and Leprosy Control Program. Algorithm for TB screening, diagnosis, and management","year":"2017"},{"key":"2026012203154661400_bib14","doi-asserted-by":"crossref","first-page":"e0220251","DOI":"10.1371\/journal.pone.0220251","article-title":"Empiric treatment of pulmonary TB in the Xpert era: correspondence of sputum culture, Xpert MTB\/RIF, and clinical diagnoses","volume":"14","author":"Kendall","year":"2019","journal-title":"PLoS One"},{"key":"2026012203154661400_bib15","volume-title":"StatPearls","author":"Weir","year":"2022"},{"key":"2026012203154661400_bib16","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1017\/S1368980020000397","article-title":"Determining a global mid-upper arm circumference cut-off to assess underweight in adults (men and non-pregnant women)","volume":"23","author":"Tang","year":"2020","journal-title":"Public Health Nutr"},{"key":"2026012203154661400_bib17","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S1473-3099(17)30691-6","article-title":"Xpert MTB\/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study","volume":"18","author":"Dorman","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2026012203154661400_bib18","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2026012203154661400_bib19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2026012203154661400_bib20","volume-title":"Uganda National Household Survey 2019\/2020","author":"Uganda Bureau of Statistics","year":"2021"},{"key":"2026012203154661400_bib21","author":"International Monetary Fund International Financial Statistics","year":"2023"},{"key":"2026012203154661400_bib22","doi-asserted-by":"crossref","first-page":"e2211045119","DOI":"10.1073\/pnas.2211045119","article-title":"Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications","volume":"119","author":"Ryckman","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012203154661400_bib23","doi-asserted-by":"crossref","first-page":"101250","DOI":"10.1016\/j.eclinm.2021.101250","article-title":"How much do smear-negative patients really contribute to tuberculosis transmissions? Re-examining an old question with new tools","volume":"43","author":"Asadi","year":"2022","journal-title":"EClinicalMedicine"},{"key":"2026012203154661400_bib24","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1038\/s41598-023-28869-6","article-title":"Xpert MTB\/RIF Ultra CT value provides a rapid measure of sputum bacillary burden and predicts smear status in patients with pulmonary tuberculosis","volume":"13","author":"Martin-Higuera","year":"2023","journal-title":"Sci Rep"},{"key":"2026012203154661400_bib25","doi-asserted-by":"crossref","first-page":"e0254002","DOI":"10.1371\/journal.pone.0254002","article-title":"Evaluation of the diagnostic performance of laboratory-based c-reactive protein as a triage test for active pulmonary tuberculosis","volume":"16","author":"Samuels","year":"2021","journal-title":"PLoS One"},{"key":"2026012203154661400_bib26","doi-asserted-by":"crossref","first-page":"e704","DOI":"10.1016\/S2214-109X(23)00113-4","article-title":"Use of point-of-care C-reactive protein testing for screening of tuberculosis in the community in high-burden settings: a prospective, cross-sectional study in Zambia and South Africa","volume":"11","author":"Ruperez","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2026012203154661400_bib27","doi-asserted-by":"crossref","first-page":"100776","DOI":"10.1016\/j.eclinm.2021.100776","article-title":"Blood-based host biomarker diagnostics in active case finding for pulmonary tuberculosis: a diagnostic case-control study","volume":"33","author":"Moreira","year":"2021","journal-title":"EClinicalMedicine"},{"key":"2026012203154661400_bib28","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1093\/cid\/ciab527","article-title":"Male sex is associated with worse microbiological and clinical outcomes following tuberculosis treatment: a retrospective cohort study, a systematic review of the literature, and meta-analysis","volume":"73","author":"Chidambaram","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026012203154661400_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2019.00163","article-title":"Sex disparity in severity of lung lesions in newly identified tuberculosis is age-associated","volume":"6","author":"Chu","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"2026012203154661400_bib30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.chest.2022.09.024","article-title":"Sex differences in TB clinical presentation, drug exposure, and treatment outcomes in India","volume":"163","author":"Deshmukh","year":"2023","journal-title":"Chest"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/6\/875\/66010735\/annalsats_21_6_875.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/21\/6\/875\/66010735\/annalsats_21_6_875.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:17:04Z","timestamp":1769069824000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/21\/6\/875\/8381968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6,1]]},"published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202308-752oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,6]]},"published":{"date-parts":[[2024,6,1]]},"assertion":[{"value":"2023-08-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}